Neuro-ophthalmology update

Journal of Neurology

Volumn 261, Issue 7, 2014, Pages 1251-1256

  Weber, Konrad P ^a,b   Straumann, Dominik ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

4 aminopyridine (4AP); Cerebellar downbeat nystagmus; Chronic relapsing inflammatory optic neuropathy (CRION); Eye movements; Neuro ophthalmology; Neuromyelitis optica (NMO); Ocular myasthenia gravis; Optic neuritis

Indexed keywords

4 AMINOPYRIDINE; AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; GLATIRAMER; MITOXANTRONE; NATALIZUMAB; PEGINTERFERON BETA1A;

DIFFERENTIAL DIAGNOSIS; HUMAN; MYASTHENIA GRAVIS; MYELOOPTIC NEUROPATHY; NEUROOPHTHALMOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; OCULOGRAPHY; OPTIC NEURITIS; PRIORITY JOURNAL; REVIEW; VIDEOOCULOGRAPHY; COMPLICATION; EYE DISEASES; FACTUAL DATABASE; NERVOUS SYSTEM DISEASES; NEUROLOGY; OPHTHALMOLOGY; STATISTICS AND NUMERICAL DATA; TRENDS;

DATABASES, FACTUAL; EYE DISEASES; HUMANS; NERVOUS SYSTEM DISEASES; NEUROLOGY; OPHTHALMOLOGY;

EID: 84904876323     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-7105-x     Document Type: Review

References (29)

1. Leigh RJ, Zee DS (2006) The neurology of eye movements, vol 4. Oxford Press, New York
2. Tseng P-H, Cameron IM, Pari G, Reynolds J, Munoz D, Itti L (2013) High-throughput classification of clinical populations from natural viewing eye movements. J Neurol 260(1):275-284. doi: 10.1007/s00415-012-6631-2
3. Linder J, Wenngren B-I, Stenlund H, Forsgren L (2012) Impaired oculomotor function in a community-based patient population with newly diagnosed idiopathic Parkinsonism. J Neurol 259(6):1206-1214. doi: 10.1007/s00415-011- 6338-9
4. Ong Y-H, Brown M, Robinson P, Plant G, Husain M, Leff A (2012) Read-right: a "web app" that improves reading speeds in patients with hemianopia. J Neurol 259(12):2611-2615. doi: 10.1007/s00415-012-6549-8
5. Weiss N, Tadie J-M, Faugeras F, Diehl J-L, Fagon J-Y, Guerot E (2012) Can fast component of nystagmus on caloric vestibulo-ocular responses predict emergence from vegetative state in ICU? J Neurol 259(1):70-76. doi: 10.1007/s00415-011-6120-z
6. Trojano L, Moretta P, Loreto V, Cozzolino A, Santoro L, Estraneo A (2012) Quantitative assessment of visual behavior in disorders of consciousness. J Neurol 259(9):1888-1895. doi: 10.1007/s00415-012-6435-4
7. Finke C, Pech L, Sömmer C, Schlichting J, Stricker S, Endres M, Ostendorf F, Ploner C, Brandt A, Paul F (2012) Dynamics of saccade parameters in multiple sclerosis patients with fatigue. J Neurol 259(12):2656-2663. doi: 10.1007/s00415-012-6565-8
8. Suzuki S, Satoh T, Yasuoka H, Hamaguchi Y, Tanaka K, Kawakami Y, Suzuki N, Kuwana M (2005) Novel autoantibodies to a voltage-gated potassium channel Kv1.4 in a severe form of myasthenia gravis. J Neuroimmunol 170(1-2):141-149. doi: 10.1016/j.jneuroim.2005.08.017
9. Romi F, Suzuki S, Suzuki N, Petzold A, Plant G, Gilhus N (2012) Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis. J Neurol 259(7):1312-1316. doi: 10.1007/s00415-011-6344-y
10. Higuchi O, Hamuro J, Motomura M, Yamanashi Y (2011) Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Annal Neurol 69(2):418-422. doi: 10.1002/ana.22312
11. Pevzner A, Schoser B, Peters K, Cosma N-C, Karakatsani A, Schalke B, Melms A, Kröger S (2012) Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis. J Neurol 259(3):427-435. doi: 10.1007/s00415-011-6194-7
12. Rajakulendran S, Viegas S, Spillane J, Howard R (2012) Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies. J Neurol 259(12):2736-2739. doi: 10.1007/s00415-012-6661-9
13. Devic E (1894) Myélite subaiguë compliquée de névrite optique. Bull Med (Paris) 8:1033-1034
14. Jarius S, Wildemann B (2012) The case of the Marquis de Causan (1804): an early account of visual loss associated with spinal cord inflammation. J Neurol 259(7):1354-1357. doi: 10.1007/s00415-011-6355-8
15. Jarius S, Wildemann B (2013) On the contribution of Thomas Clifford Allbutt, F.R.S., to the early history of neuromyelitis optica. J Neurol 260(1):100-104. doi: 10.1007/s00415-012-6594-3
16. Jacob A, Panicker J, Lythgoe D, Elsone L, Mutch K, Wilson M, Das K, Boggild M (2013) The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of UK. J Neurol 260(8):2134-2137. doi: 10.1007/s00415-013- 6926-y
17. Uzawa A, Mori M, Muto M, Masuda S, Kuwabara S (2012) When is neuromyelitis optica diagnosed after disease onset? J Neurol 259(8):1600-1605. doi: 10.1007/s00415-011-6384-3
18. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10):1485-1489. doi: 10.1212/01.wnl.0000216139.44259.74
19. Iorio R, Damato V, Mirabella M, Evoli A, Marti A, Plantone D, Frisullo G, Batocchi A (2013) Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies. J Neurol 260(9):2396-2402. doi: 10.1007/s00415-013-6997-9
20. Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X, Du Pasquier RA, Polman CH, Sorensen PS, Hemmer B (2010) EFNS guidelines on diagnosis and management of neuromyelitis optica. Euro J Neurol Off J Euro Fed Neurol Soc 17(8):1019-1032. doi: 10.1111/j.1468-1331.2010.03066.x
21. Kageyama T, Komori M, Miyamoto K, Ozaki A, Suenaga T, Takahashi R, Kusunoki S, Matsumoto S, Kondo T (2013) Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica. J Neurol 260(2):627-634. doi: 10.1007/s00415-012-6692-2
22. Juryńczyk M, Zaleski K, Selmaj K (2013) Natalizumab and the development of extensive brain lesions in neuromyelitis optica. J Neurol 260(7):1919-1921. doi: 10.1007/s00415-013-6965-4
23. Horwitz H, Degn M, Modvig S, Larsson HW, Wanscher B, Frederiksen J (2012) CSF abnormalities can be predicted by VEP and MRI pathology in the examination of optic neuritis. J Neurol 259(12):2616-2620. doi: 10.1007/s00415-012-6551-1
24. Kidd D, Burton B, Plant GT, Graham EM (2003) Chronic relapsing inflammatory optic neuropathy (CRION). Brain J Neurol 126(Pt 2):276-284
25. Petzold A, Plant G (2013) Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported. J Neurol. doi: 10.1007/s00415-013-6957-4
26. Claassen J, Feil K, Bardins S, Teufel J, Spiegel R, Kalla R, Schneider E, Jahn K, Schniepp R, Strupp M (2013) Dalfampridine in patients with downbeat nystagmus - an observational study. J Neurol 260(8):1992-1996. doi: 10.1007/s00415-013-6911-5
27. Shaikh AG, Marti S, Tarnutzer AA, Palla A, Crawford TO, Zee DS, Straumann D (2013) Effects of 4-aminopyridine on nystagmus and vestibulo-ocular reflex in ataxia-telangiectasia. J Neurol. doi: 10.1007/s00415-013-7046-4
28. Kremmyda O, Zwergal A, Fougère C, Brandt T, Jahn K, Strupp M (2013) 4-Aminopyridine suppresses positional nystagmus caused by cerebellar vermis lesion. J Neurol 260(1):321-323. doi: 10.1007/s00415-012-6737-6
29. Feil K, Claaßen J, Bardins S, Teufel J, Habs M, Kalla R, Strupp M (2013) Transition from downbeat to upbeat nystagmus caused by 4-aminopyridine. J Neurol 260(5):1426-1428. doi: 10.1007/s00415-013-6907-1